Critical roles of platelets in lipopolysaccharide-induced lethality: Effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome

International Immunopharmacology

Volumn 5, Issue 3, 2005, Pages 571-580

  Yu, Zhiqian ^a   Ohtaki, Yuko ^a   Kai, Kenzou ^b   Sasano, Takashi ^a   Shimauchi, Hidetoshi ^a   Yokochi, Takashi ^c   Takada, Haruhiko ^a   Sugawara, Shunji ^a   Kumagai, Katsuo ^b   Endo, Yasuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b T CELL Research Institute Ltd   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; Glycyrrhizin; Lipopolysaccharide; Platelets; Severe acute respiratory syndrome; Shock

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; LIPOPOLYSACCHARIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; GLYCYRRHIZA; HEPATITIS C; IMMUNOPHARMACOLOGY; JAPAN; LETHAL DOSE; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SHOCK; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM;

EID: 20144364744     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.11.004     Document Type: Article

References (57)

1. M.A. Martin, and H.J. Silverman Gram-negative sepsis and the adult respiratory distress syndrome Clin. Infect. Dis. 14 1992 1213 1228
2. S.M. Opal, and T. Glück Endotoxin as a drug target Crit. Care Med. 31 2003 S57 S64
3. S.A. Nasraway The problems and challenges of immunotherapy in sepsis Chest 123 2003 S451 S459
4. C.T. Esmon Protein C pathway in sepsis Ann. Med. 34 2002 598 605
5. B.D. Freeman, and T.G. Buchman Coagulation inhibitors in the treatment of sepsis Expert Opin. Investig. Drugs 11 2002 69 74
6. J.E. Heffner, S.A. Sahn, and J.E. Repin The role of platelets in the adult respiratory distress syndrome. Culprits or bystanders? Am. Rev. Respir. Dis. 135 1987 482 492
7. M. Gawaz, T. Dickfeld, C. Bogner, S. Fateh-Moghadam, and F.J. Neumann Platelet function in septic multiple organ dysfunction syndrome Intensive Care Med. 23 1997 379 385
8. Y. Ohtaki, H. Shimauchi, T. Yokochi, H. Takada, and Y. Endo In vivo platelet response to lipopolysaccharide in mice: proposed method for evaluating new antiplatelet drugs Thromb. Res. 108 2002 303 309
9. M. Shibazaki, Y. Kawabata, T. Yokochi, A. Nishida, H. Takada, and Y. Endo Complement-dependent accumulation and degradation of platelets in the lung and liver induced following injection of lipopolysaccharides Infect. Immun. 67 1999 5186 5191
10. L. Zhao, Y. Ohtaki, K. Yamaguchi, M. Matsushita, T. Fujita, and T. Yokochi LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system Blood 100 2002 3233 3239
11. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to lethal effects of endotoxin Proc. Natl. Acad. Sci. U. S. A. 76 1979 5939 5943
12. V. Lehmann, M.A. Freudenberg, and C. Galanos Lethal toxicity and tumor necrosis factor in normal and D-galactosamine-treated mice J. Exp. Med. 165 1987 657 663
13. Y. Endo, T. Kikuchi, and M. Nakamura Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 and tumour necrosis factor by D-galactosamine Br. J. Pharmacol. 107 1992 888 894
14. C.A. Dinarello Anti-cytokine therapeutics and infections Vaccine 21 2003 S2/24 S2/34
15. R. Pompei, O. Flore, M.A. Marccialis, A. Pani, and B. Loddo Glycyrrhizic acid inhibits virus growth and inactivates virus particles Nature 281 1979 689 690
16. T. Utsunomiya, M. Kobayashi, R.B. Pollard, and F. Suzuki Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal dose of influenza virus Antimicrob. Agents Chemother. 41 1997 551 556
17. T. Okamoto The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice Eur. J. Pharmacol. 387 2000 229 232
18. K. Ohuchi, Y. Kamada, and S. Tsurufuji Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats Prostaglandins Med. 7 1981 457 463
19. N. Imanishi, H. Kawai, Y. Hayashi, K. Yatsunami, and A. Ichikawa Effects of glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release from rat peritoneal mast cells Biochem. Pharmacol. 38 1989 2521 2526
20. Y.-M. Lee, S. Hirota, T. Jippo-Kanemoto, H.-R. Kim, T.-Y. Shin, and Y. Yeon Inhibition of histamine synthesis by glycyrrhetinic acid in mast cells cocultured with Swii 3T3 fibroblasts Int. Arch. Allergy Immunol. 110 1996 272 277
21. K. Kai, K. Komine, K. Asai, T. Kuroishi, Y. Komine, and T. Kozutsumi Anti-inflammatory effects of intramammary infusion of glycyrrhizin in lactating cows with mastitis caused by coagulase-negative staphylococci Am. J. Vet. Res. 64 2003 1213 1220
22. B.H. Kroes, C.J. Beukelman, A.J.J. Van Den Berg, G.J. Wolbink, H. Van Dijk, and R.P. Labadie Inhibition of human complement by β-glycyrrhetinic acid Immunology 90 1997 115 120
23. Y. Fujisawa, M. Sakamoto, M. Matsushita, T. Fujita, and K. Nishioka Glycyrrhizin inhibits the lytic pathway of complement: possible mechanism of its anti-inflammatory effect on liver Microbiol. Immunol. 44 2000 799 804
24. Y. Arase, K. Ikeda, N. Murashima, K. Chayama, A. Tsubota, and I. Koida The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494 1500
25. T.G.J. Van Rossum, A.G. Vulto, W.C.J. Hop, J.T. Brouwer, H.G.M. Niesters, and S.W. Schalm Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial J. Gastroenterol. Hepatol. 14 1999 1093 1099
26. T. Yokochi, Y. Inoue, J. Yokoo, Y. Kimura, and N. Kato Retention of bacterial lipopolysaccharide at the site of subcutaneous injection Infect. Immun. 57 1989 1786 1791
27. Y. Nagata, H. Nagahisa, Y. Aida, K. Okutomi, T. Nagasawa, and K. Todokoro Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells J. Biol. Chem. 270 1995 19673 19675
28. Y. Nagata, Y. Shozaki, H. Nagahisa, T. Nagasawa, T. Abe, and K. Todokoro Serumthrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis Thromb. Haemost. 77 1997 808 814
29. Y. Endo, and M. Nakamura The effects of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse Br. J. Pharmacol. 105 1992 613 619
30. I.D.J. Bross How to use ridit analysis Biometrics 4 1958 18 38
31. A. Yoshida, M. Ohba, X. Wu, T. Sasano, M. Nakamura, and Y. Endo Accumulation of platelets in the lung and liver and their degranulation following antigen-challenge in sensitized mice Br. J. Pharmacol. 137 2002 146 152
32. I.M.B. Francischetti, R.Q. Monteiro, and J.A. Guimarães Identification of glycyrrhizin as a thrombin inhibitor Biochem. Biophys. Res. Commun. 235 1997 259 263
33. W. Mendes-Silva, M. Assafim, B. Ruta, R.Q. Monteiro, J.A. Guimarães, and R.B. Zingali Antithrombotic effect of glycyrrhizin, a plant-derived thrombin inhibitor Thromb. Res. 112 2003 93 98
34. T.C. Farries, and J.P. Atkinson Evolution of the complement system Immunol. Today 12 1991 295 300
35. T. Fujita, Y. Endo, and M. Nonaka Primitive complement system: recognition and activation Mol. Immunol. 41 2004 103 111
36. J.S. Presanis, K. Hajela, G. Ambrus, P. Gál, and R.B. Sim Differential substrate and inhibitor profiles for human MASP-1 and NASP-2 Mol. Immunol. 40 2003 921 929
37. P.J. Sims, and T. Wiedmer The response of human platelets to activated components of the complement system Immunol. Today 12 1991 338 342
38. D.L. Mattson Comparison of arterial blood pressure in different strains of mice Am. J. Hypertens. 14 2001 405 408
39. T. Miyake, M. Saito, and K. Shimura Adsorption, excretion and distribution of 3H-glycyrrhizin in mice (in Japanese) Minophagen Med. Rev. 24 1979 263 272
40. S. Ishiwata, K. Nakashita, M. Niizeki, N. Suzuki, S. Kaneko, and Y. Tomioka Determination of serum concentration of glycyrrhizin in humans by semi-micro high-performance liquid chromatography after administration of a therapeutic dose Biol. Pharm. Bull. 23 2000 904 905
41. S. Takeda, K. Ishihara, Y. Wakui, S. Amagaya, M. Maruno, and T. Akao Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats: relevance to the intestinal bacterial hydrolysis J. Pharm. Pharmacol. 48 1996 902 905
42. R. MacLaren, and R. Jung Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults Pharmacotherapy 22 2002 1140 1156
43. P. Minneci, K. Deans, C. Natanson, and P.Q. Eichacker Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis Eur. J. Clin. Microbiol. Infect. Dis. 22 2000 1 9
44. B.D. Freeman, and C. Natanson Anti-inflammatory therapies in sepsis and septic shock Expert Opin. Invest. Drugs 9 2000 1651 1663
45. N. Abe, T. Ebina, and N. Ishida Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice Microbiol. Immunol. 26 1982 535 539
46. J.H. Dai, Y. Iwatani, T. Ishida, H. Terunuma, H. Kasai, and Y. Iwakura Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages Immunology 103 2001 235 243
47. T. Utsunomiya, M. Kobayashi, M. Ito, D.N. Herndon, R.B. Pollard, and F. Suzuki Glycyrrhizin restores the impaired IL-12 production in thermally injured mice Cytokine 14 2001 49 55
48. I.J. Elenkov, G.P. Chrousos, and R.L. Wilder Neuroendocrine regulation of IL-12 and TNF-α/IL-10 balance Ann. N.Y. Acad. Sci. 917 2000 94 105
49. E. Schneider, M. Rolli-Derkinderen, M. Arock, and M. Dy Trends in histamine research: new functions during immune responses and hematopoiesis Trends Immunol. 23 2002 255 263
50. K. Weiss Pulmonary thromboembolism: epidemiology and techniques of nuclear medicine Semin. Thromb. Hemost. 22 1996 27 32
51. C.M. Herd, and C.P. Page Pulmonary immune cells in health and disease: platelets Eur. Respir. J. 7 1994 1145 1160
52. Y. Isobe "Streptococcus milleri" group induce anaphylactoid reaction and inflammatory cytokines in mice primed with muramyldipeptide J. Dent. Health 48 1998 170 182 [abstract in English]
53. M. Ohba, M. Shibazaki, T. Sasano, M. Inoue, H. Takada, and Y. Endo Platelet responses and anaphylaxis-like shock induced in mice by intravenous injection of whole cells of oral streptococci Oral Microbiol. Immunol. 19 2004 26 30
54. M.C. Herzberg, and M.W. Meyer Dental plaque, platelets, and cardiovascular diseases Ann. Periodontol. 3 1998 151 160
55. R.S.M. Wong, A. Wu, K.F. To, N. Lee, C.W.K. Lam, and C.K. Wong Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis Br. Med. J. 326 2003 1358 1362
56. J.S.M Peiris, C.M. Chu, V.C.C. Cheng, K.S. Chan, I.F.N. Hung, L.L.M. Poon members of the HKU/UCH SARS Study Group Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 2003 1767 1772
57. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Ravenau, and H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045 2046